Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

Somatic genomic mosaicism in the brain during aging: Scratching the surface
Bae, Taejeong , Abyzov, Alexej , Abyzov, Alexej , Bae, Taejeong , Wang, Yifan , Vaccarino, Flora M.

Mayo Clinic

Clinical and Translational Medicine | December 10, 2022 | Volume: 12 | Issue: 12 | Pages: No page available

10.1002/ctm2.1138 | PMID 36495113 Get It

Cloned antibodies from patients with HIT provide new clues to HIT pathogenesis
Zhu, Wen , Zheng, Yongwei , Yu, Mei , Wu, Ya‐Ling , Wei, Jianhui, Fu, Guoping, Schneider, Nicholas O. , Jones, Curtis G., Irani, Mehraboon S. , Padmanabhan, Anand , Aster, Richard H. , Wang, Demin , Wen, Renren , Zhou, Lu , Schneider, Nicholas , Padmanabhan, Anand , Wang, Demin , Wen, Renren , Yu, Mei, Wu, Yaling, Lü, Zhou , Zhou, Lu

Mayo Clinic

Blood | December 9, 2022 | Volume: 141 | Issue: 9 | Pages: 1060-1069

10.1182/blood.2022017612 | PMID 36493339 Get It

AbstractHeparin-induced thrombocytopenia (HIT) is a serious adverse drug reaction characterized by antibodies that recognize platelet factor 4/heparin complexes (PF4/H) and activate platelets to create a prothrombotic state. Although a high percentage of heparin-treated patients produce antibodies to PF4/H, only a subset also makes antibodies that are platelet activating (PA). A close correlation between PA antibodies and the likelihood of experiencing HIT has been demonstrated in clinical studies, but how PA (presumptively pathogenic) and nonactivating (NA) (presumptively benign) antibodies differ from each other at the molecular level is unknown. To address this issue, we cloned 7 PA and 47 NA PF4/H-binding antibodies from 6 patients with HIT and characterized their structural and functional properties. Findings showed that PA clones differed significantly from NA clones in possessing 1 of 2 heavy chain complementarity-determining region 3 (HCDR3) motifs, RX1-2R/KX1-2R/H (RKH) and YYYYY (Y5), in an unusually long complementarity-determining region 3 (≥20 residues). Mutagenic studies showed that modification of either motif in PA clones reduced or abolished their PA activity and that appropriate amino acid substitutions in HCDR3 of NA clones can cause them to become PA. Repertoire sequencing showed that the frequency of peripheral blood IgG+ B cells possessing RKH or Y5 was significantly higher in patients with HIT than in patients without HIT given heparin, indicating expansion of B cells possessing RKH or Y5 in HIT. These findings imply that antibodies possessing RKH or Y5 are relevant to HIT pathogenesis and suggest new approaches to diagnosis and treatment of this condition.
Usp22 is an intracellular regulator of systemic emergency hematopoiesis
Dietlein, Nikolaus , Wang, Xi , Metz, Jonas , Disson, Olivier , Shang, Fuwei , Beyersdörffer, Celine, Rodriguez-Correa, Esther , Lipka, Daniel B. , Begus‐Nahrmann, Yvonne, Kosinsky, Robyn Laura , Johnsen, Steven A. , Lecuit, Marc , Rodewald, Hans‐Reimer , Höfer, Thomas , Rodewald, Hans-Reimer , Johnsen, Steven A , Kosinsky, Robyn Laura

Mayo Clinic

Science Immunology | December 9, 2022 | Volume: 7 | Issue: 78 | Pages: No page available

10.1126/sciimmunol.abq2061 | PMID 36490327 Get It

Emergency hematopoiesis is a concerted response aimed toward enhanced protection from infection, involving multiple cell types and developmental stages across the immune system. Despite its importance, the underlying molecular regulation remains poorly understood. The deubiquitinase USP22 regulates the levels of monoubiquitinated histone H2B (H2Bub1), which is associated with activation of interferon responses upon viral infection. Here, we show that in the absence of infection or inflammation, mice lacking Usp22 in all hematopoietic cells display profound systemic emergency hematopoiesis, evident by increased hematopoietic stem cell proliferation, myeloid bias, and extramedullary hematopoiesis. Functionally, loss of Usp22 results in elevated phagocytosis by neutrophilic granulocytes and enhanced innate protection against Listeria monocytogenes infection. At the molecular level, we found this state of emergency hematopoiesis associated with transcriptional signatures of myeloid priming, enhanced mitochondrial respiration, and innate and adaptive immunity and inflammation. Augmented expression of many inflammatory genes was linked to elevated locus-specific H2Bub1 levels. Collectively, these results demonstrate the existence of a tunable epigenetic state that promotes systemic emergency hematopoiesis in a cell-autonomous manner to enhance innate protection, identifying potential paths toward immune enhancement.
JSENSE‐Pro: Joint sensitivity estimation and image reconstruction in parallel imaging using pre‐learned subspaces of coil sensitivity functions
Tang, Lihong , Zhao, Yibo , Li, Yudu , Guo, Rong , Cai, Bingyang, Wang, Jia , Li, Yao , Liang, Zhi‐Pei , Peng, Xi , Luo, Jie , Yang, H. J. , Peng, Xi

Mayo Clinic

Magnetic Resonance in Medicine | December 8, 2022 | Volume: 89 | Issue: 4 | Pages: 1531-1542

10.1002/mrm.29548 | PMID 36480000 Get It

PurposeTo improve calibrationless parallel imaging using pre‐learned subspaces of coil sensitivity functions.Theory and MethodsA subspace‐based joint sensitivity estimation and image reconstruction method was developed for improved parallel imaging with no calibration data. Specifically, we proposed to use a probabilistic subspace model to capture prior information of the coil sensitivity functions from previous scans acquired using the same receiver system. Both the subspace basis and coefficient distributions were learned from a small set of training data. The learned subspace model was then incorporated into the regularized reconstruction formalism that includes a sparsity prior. The nonlinear optimization problem was solved using alternating minimization algorithm. Public fastMRI brain dataset was retrospectively undersampled by different schemes for performance evaluation of the proposed method.ResultsWith no calibration data, the proposed method consistently produced the most accurate coil sensitivity estimation and highest quality image reconstructions at all acceleration factors tested in comparison with state‐of‐the‐art methods including JSENSE, DeepSENSE, P‐LORAKS, and Sparse BLIP. Our results are comparable to or even better than those from SparseSENSE, which used calibration data for sensitivity estimation. The work also demonstrated that the probabilistic subspace model learned from T2w data can be generalized to aiding the reconstruction of FLAIR data acquired from the same receiver system.ConclusionA subspace‐based method named JSENSE‐Pro has been proposed for accelerated parallel imaging without the acquisition of companion calibration data. The method is expected to further enhance the practical utility of parallel imaging, especially in applications where calibration data acquisition is not desirable or limited.
Examination of Tobacco-Related Messaging and Tobacco Use over Time among U.S. Military Young Adults
Wang, Xin-Qun , Fahey, Margaret C. , Patten, Christi A. , Talcott, G. Wayne , Klesges, Robert C. , Little, Melissa A. , Fahey, Margaret C , Patten, Christi , Pebley, Kinsey , Mallawaarachchi, Indika V.

Mayo Clinic

Substance Use & Misuse | December 8, 2022 | Volume: 58 | Issue: 1 | Pages: 146-152

10.1080/10826084.2022.2151313 | PMID 36476101 Get It

Recommended practices and ethical considerations for natural language processing‐assisted observational research: A scoping review
Fu, Sunyang , Wang, Liwei , Moon, Sungrim , Zong, Nansu , Pejaver, Vikas , Relevo, Rose , Walden, Anita , Haendel, Melissa , Chute, Christopher G. , He, Huan , Pejaver, Vikas , Walden, Anita , Haendel, Melissa , Chute, Christopher G , Liu, Hongfang , Fu, Sunyang , Moon, Sungrim , He, Huan , Liu, Hongfang

Mayo Clinic

Clinical and Translational Science | December 7, 2022 | Volume: 16 | Issue: 3 | Pages: 398-411

10.1111/cts.13463 | PMID 36478394 Get It

AbstractAn increasing number of studies have reported using natural language processing (NLP) to assist observational research by extracting clinical information from electronic health records (EHRs). Currently, no standardized reporting guidelines for NLP‐assisted observational studies exist. The absence of detailed reporting guidelines may create ambiguity in the use of NLP‐derived content, knowledge gaps in the current research reporting practices, and reproducibility challenges. To address these issues, we conducted a scoping review of NLP‐assisted observational clinical studies and examined their reporting practices, focusing on NLP methodology and evaluation. Through our investigation, we discovered a high variation regarding the reporting practices, such as inconsistent use of references for measurement studies, variation in the reporting location (reference, appendix, and manuscript), and different granularity of NLP methodology and evaluation details. To promote the wide adoption and utilization of NLP solutions in clinical research, we outline several perspectives that align with the six principles released by the World Health Organization (WHO) that guide the ethical use of artificial intelligence for health.
A Systematic Review Supporting the Endocrine Society Guidelines: Management of Diabetes and High Risk of Hypoglycemia
Roldan, Victor D. Torres , Urtecho, Meritxell , Nayfeh, Tarek , Firwana, Mohammed , Muthusamy, Kalpana , Abd‐Rabu, Rami , Maraboto, Andrea , Qoubaitary, Amjad, Lieb, David C. , McCall, Anthony L. , Torres Roldan, Victor D , Hasan, Bashar , Abd-Rabu, Rami, Murad, Mohammad Hassan, Nayfeh, Tarek , Firwana, Mohammed M , Hasan, Bashar , Prokop, Larry J. , Wang, Zhen , Murad, M. Hassan

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | December 7, 2022 | Volume: 108 | Issue: 3 | Pages: 592-603

10.1210/clinem/dgac601 | PMID 36477885 Get It

Abstract Context Interventions targeting hypoglycemia in people with diabetes are important for improving quality of life and reducing morbidity and mortality. Objective To support development of the Endocrine Society Clinical Practice Guideline for management of individuals with diabetes at high risk for hypoglycemia. Methods We searched several databases for studies addressing 10 questions provided by a guideline panel from the Endocrine Society. Meta-analysis was conducted when feasible. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was used to assess certainty of evidence. Results We included 149 studies reporting on 43 344 patients. Continuous glucose monitoring (CGM) reduced episodes of severe hypoglycemia in patients with type 1 diabetes (T1D) and reduced the proportion of patients with hypoglycemia (blood glucose [BG] levels <54 mg/dL). There were no data on use of real-time CGM with algorithm-driven insulin pumps vs multiple daily injections with BG testing in people with T1D. CGM in outpatients with type 2 diabetes taking insulin and/or sulfonylureas reduced time spent with BG levels under 70 mg/dL. Initiation of CGM in hospitalized patients at high risk for hypoglycemia reduced episodes of hypoglycemia with BG levels lower than 54 mg/dL and time spent under 54 mg/dL. The proportion of patients with hypoglycemia with BG levels lower than 70 mg/dL and lower than 54 mg/dL detected by CGM was significantly higher than point-of-care BG testing. We found no data evaluating continuation of personal CGM in the hospital. Use of an inpatient computerized glycemic management program utilizing electronic health record data was associated with fewer patients with and episodes of hypoglycemia with BG levels lower than 70 mg/dL and fewer patients with severe hypoglycemia compared with standard care. Long-acting basal insulin analogs were associated with less hypoglycemia. Rapid-acting insulin analogs were associated with reduced severe hypoglycemia, though there were more patients with mild to moderate hypoglycemia. Structured diabetes education programs reduced episodes of severe hypoglycemia and time below 54 mg/dL in outpatients taking insulin. Glucagon formulations not requiring reconstitution were associated with longer times to recovery from hypoglycemia, although the proportion of patients who recovered completely from hypoglycemia was not different between the 2 groups. Conclusion This systematic review summarized the best available evidence about several interventions addressing hypoglycemia in people with diabetes. This evidence base will facilitate development of clinical practice guidelines by the Endocrine Society.
Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor–Positive Breast Cancer
Wei, Lixuan , Gao, Huanyao , Yu, Jia , Zhang, Huan , Nguyen, Thanh Thanh L. , Gu, Yayun , Passow, Marie R. , Carter, Jodi M. , Qin, Bo , Boughey, Judy C. , Weinshilboum, Richard M. , Wang, Liewei , Boughey, JC , Goetz, Matthew P , Weinshilboum, Richard M. , Ingle, J , Wang, Liewei , Nguyen, Thanh Thanh L. , Carter, Jodi , Goetz, Matthew P. , Ingle, James N.

Mayo Clinic

Cancer Research | December 5, 2022 | Volume: 83 | Issue: 3 | Pages: 456-470

10.1158/0008-5472.can-22-1016 | PMID 36469363 Get It

Abstract Androgen receptor (AR) is expressed in 80% to 90% of estrogen receptor α–positive (ER+) breast cancers. Accumulated evidence has shown that AR is a tumor suppressor and that its expression is associated with improved prognosis in ER+ breast cancer. However, both a selective AR agonist (RAD140) and an AR inhibitor (enzalutamide, ENZ) have shown a therapeutic effect on ER+ breast cancer, so the potential for clinical application of AR-targeting therapy for ER+ breast cancer is still in dispute. In this study, we evaluated the efficacy of ENZ and RAD140 in vivo and in vitro in AR+/ER+ breast cancer models, characterizing the relationship of AR and ER levels to response to AR-targeting drugs and investigating the alterations of global gene expression and chromatin binding of AR and ERα after ENZ treatment. In the AR-low setting, ENZ directly functioned as an ERα antagonist. Cell growth inhibition by ENZ in breast cancer with low AR expression was independent of AR and instead dependent on ER. In AR-high breast cancer models, AR repressed ERα signaling and ENZ promoted ERα signaling by antagonizing AR. In contrast, RAD140 activated AR signaling and suppressed AR-high tumor growth by deregulating ERα expression and blocking ERα function. Overall, analysis of the dynamic efficacies and outcomes of AR agonist, and antagonist in the presence of different AR and ERα levels reveals regulators of response and supports the clinical investigation of ENZ in selected ER+ tumors with a low AR/ER ratio and AR agonists in tumors with a high AR/ER ratio. Significance: The ratio of androgen receptor to estrogen receptor in breast cancer dictates the response to AR-targeted therapies, providing guidelines for developing AR-directed treatment strategies for patients with breast cancer.
Effects of age and time since injury on traumatic brain injury blood biomarkers: a TRACK-TBI study
Puccio, Ava M. , Korley, Frederick K. , Okonkwo, David O. , Puffer, Ross C. , Yuh, Esther L. , Yue, John K. , Sun, Xiaoying, Taylor, Sabrina R. , Mukherjee, Pratik , Jain, Sonia , Manley, Geoffrey T. , Investigators, the TRACK-TBI, Feeser, V. Ramana, Ferguson, Adam R. , Gaudette, Etienne, Gopinath, Shankar P. , McCrea, Michael , Merchant, Randall E., Robertson, Claudia S. , Vassar, Mary J. , Zafonte, Ross , Mukherjee, Pratik , Gardner, Raquel C. , Wang, Kevin , Diaz‐Arrastia, Ramon , Investigators, the TRACK-TBI, Gaudette, Etienne, Keene, C. Dirk , Madden, Christopher, Martin, Alastair J. , Ngwenya, Laura Benjamin , Temkin, Nancy R.

Mayo Clinic

Brain Communications | November 30, 2022 | Volume: 5 | Issue: 1 | Pages: No page available

10.1093/braincomms/fcac316 | PMID 36642999 Get It

Abstract Older adults have the highest incidence of traumatic brain injury globally. Accurate blood-based biomarkers are needed to assist with diagnosis of patients across the spectrum of age and time post-injury. Several reports have suggested lower accuracy for blood-based biomarkers in older adults, and there is a paucity of data beyond day-1 post-injury. Our aims were to investigate age-related differences in diagnostic accuracy and 2-week evolution of four leading candidate blood-based traumatic brain injury biomarkers—plasma glial fibrillary acidic protein, ubiquitin carboxy-terminal hydrolase L1, S100 calcium binding protein B and neuron-specific enolase—among participants in the 18-site prospective cohort study Transforming Research And Clinical Knowledge in Traumatic Brain Injury. Day-1 biomarker data were available for 2602 participants including 2151 patients with traumatic brain injury, 242 orthopedic trauma controls and 209 healthy controls. Participants were stratified into 3 age categories (young: 17–39 years, middle-aged: 40–64 years, older: 65–90 years). We investigated age-stratified biomarker levels and biomarker discriminative abilities across three diagnostic groups: head CT-positive/negative; traumatic brain injury/orthopedic controls; and traumatic brain injury/healthy controls. The difference in day-1 glial fibrillary acidic protein, ubiquitin carboxy-terminal hydrolase L1 and neuron-specific enolase levels across most diagnostic groups was significantly smaller for older versus younger adults, resulting in a narrower range within which a traumatic brain injury diagnosis may be discriminated in older adults. Despite this, day-1 glial fibrillary acidic protein had good to excellent performance across all age-categories for discriminating all three diagnostic groups (area under the curve 0.84–0.96; lower limit of 95% confidence intervals all >0.78). Day-1 S100 calcium-binding protein B and ubiquitin carboxy-terminal hydrolase L1 showed good discrimination of CT-positive versus negative only among adults under age 40 years within 6 hours of injury. Longitudinal blood-based biomarker data were available for 522 hospitalized patients with traumatic brain injury and 24 hospitalized orthopaedic controls. Glial fibrillary acidic protein levels maintained good to excellent discrimination across diagnostic groups until day 3 post-injury irrespective of age, until day 5 post-injury among middle-aged or younger patients and until week 2 post-injury among young patients only. In conclusion, the blood-based glial fibrillary acidic protein assay tested here has good to excellent performance across all age-categories for discriminating key traumatic brain injury diagnostic groups to at least 3 days post-injury in this trauma centre cohort. The addition of a blood-based diagnostic to the evaluation of traumatic brain injury, including geriatric traumatic brain injury, has potential to streamline diagnosis.
Abstract 148: A Tissue-specific Crispr/cas9 Vector System For Conditional Gene Disruption In Zebrafish Reveal The Role Of Neuropilin-1 In Heart Regeneration
Mukhopadhyay, Debabrata , Angom, Ramcharan Singh , Wang, Ying

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | November 30, 2022 | Volume: 42 | Issue: Suppl_1 | Pages: No page available

10.1161/atvb.42.suppl_1.148 Get It

CRISPR/Cas9 technology-mediated genome editing has significantly improved inactivation of genes both in vitro and in vivo in many organisms in a targeted manner. This study reports a novel CRISPR-based vector system for tissue-specific gene inactivation in zebrafish. In this vector, the cardiac-specific, cardiac myosin light chain 2 ( cmlc2) promoter drives the Cas9 expression to silence the neuropilin1(nrp1) gene in cardiomyocytes in a heat-shock inducible manner. This vector system establishes an inimitable tool to regulate the gene knockout in both the developmental and adult stages. Hence, it widens the possibility of loss-of-function studies in zebrafish at different stages of development. In contrast to mammals, adult zebrafish hearts can regenerate after an injury. Neuropilins (nrp) are co-receptors that have been reported earlier to play crucial roles in zebrafish heart regeneration. Using this novel tool, we investigated the role of neuropilin isoforms, nrp1a and nrp1b, in response to cardiac injury and regeneration in adult zebrafish hearts. We observed that both the isoforms ( nrp1a and nrp1b ) are upregulated in the injured heart. Interestingly, the nrp1b -knockout significantly altered heart regeneration and reduced heart function, including heart rate, ejection fraction, and fractional shortening in the adult zebrafish. Moreover, the knockdown of nrp1b , but not nrp1a, further induces the cardiac remodeling genes activation in response to cryoinjury. These results identify a crucial role for nrp1b isoform in zebrafish heart function. To our knowledge, this is the first study where we have reported a heat shock-mediated conditional knockdown of nrp1a and nrp1b isoforms in the heart by using CRISPR/Cas9 technology and reveal a new molecular role of neuropilins in cardiac regeneration.